课题基金 / 基金详情

Gene therapy for autoimmune diabetes by DNA vaccine

Gene therapy for autoimmune diabetes by DNA vaccine
DNA疫苗治疗自身免疫性糖尿病的基因疗法
批准号:
13660318
负责人:
HAYASHI Toshiharu
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

HAYASHI Toshiharu的其他基金

相似基金

相关文献

中文摘要
翻译
DNA疫苗对自身免疫性糖尿病基因治疗的研究综述如下。(1) th1主导的全身免疫反应参与自身免疫性胰岛素的发展,可能通过il -12诱导和il -18激活的机制诱导。(2)层粘连蛋白的表达与NZBxNZWf1小鼠颌下腺的细胞浸润有关。(3) C57BL/6小鼠支气管病变的减少至少部分是由于抑制Th2免疫反应,Th2免疫反应是导致淋巴细胞和嗜酸性粒细胞浸润支气管粘膜减少的基础。(4) NZBxNZWF1小鼠血清IFN-r升高可能与活动性疾病相关。(5)哺乳小鼠感染Reo-2引起的胰岛素炎是由免疫反应引起的。(6)系统给药ifn -r表达质粒可能具有调节Th1/Th2平衡的能力,通过Th1和Th2细胞间的相互抑制机制下调Th2应答,导致LAR降低。(7) IFN-r参与了NZBxNZWF1小鼠狼疮的发展,而IL-4没有参与。(8) ifn -r编码质粒促进reo -2诱导糖尿病的自身免疫性胰岛素。(9) CpG ODN可能通过Th1细胞因子特别是IFN-r的附加作用,促进reo -2诱导的针对胰岛细胞的自身免疫反应。(10) ICAM-1/LFA-1可能是由Th0细胞向Th1细胞分化所必需的,而Th1细胞介导了reo -2感染的哺乳小鼠的胰岛素炎症。
英文摘要
Summary consisted of 10 items listed bellow concerning gene therapy for autoimmune diabetes by DNA vaccine. (1)Th1-dominant systemic immune responses, being responsible for the development of autoimmune insulitis, might be induced by IL-12-induced and IL-18-activated mechanisms. (2)Laminin expression is associated with the cellular infiltration of the submandibular salivary gland of NZBxNZWf1 mice. (3) The reduced bronchial lesions in C57BL/6 mice were due, at least in part, to suppression of the Th2 immune response that underlies the decreased infiltration of lymphocytes and eosinophils into the bronchial mucosa. (4) Increase in serum IFN-r may be associated with the active disease in NZBxNZWF1 mice. (5) The insulitis seen in Reo-2 infection in suckling mice is induced by an immune reaction. (6) The systemic administration of IFN-r-expressing plasmid may have a modulating ability of Th1/Th2 balance to down-regulate Th2 response by mutual inhibitoru mechanisms between Th1 and Th2 cells, leading to the reduction of th LAR. (7) IFN-r but not IL-4 contribute to the development of lupus in the NZBxNZWF1 mice. (8) The IFN-r-encoding plasmid promoted autoimmune insulitis in Reo-2-induced diabetes. (9) CpG ODN may contribute to accelerate Reo-2-induced autoimmune reaction against pancreatic islet cells via additional effects of Th1 cytokine especially IFN-r. (10) ICAM-1/LFA-1 may be required for the differentiation of Th0 cells to Th1 cells, which mediate insulitis with IGT in Reo-2-infected suckling mice.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Hayashi T., et al.: "Effect of antibodies to ICAM-1 and LFA-1 on cytokine mRNA expression in reovirus type-2-triggered autoimmune insulitis in DBA/1 suckling mice"J. Comp. Path.. 128. 283-288 (2003)
Hayashi T. 等人:“ICAM-1 和 LFA-1 抗体对 DBA/1 乳鼠中 2 型呼肠孤病毒引发的自身免疫性胰岛炎的细胞因子 mRNA 表达的影响”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hayashi, T., Maeda, K., Hasegawa, K., Nakai, S., Hamachi, T., Iwta, H.: "Interferon-r expressing-plasmid DNA reduces late allergic bronchitis in a Mouse model of asthma"Int. J. Exp. Path.. (In peess). (2002)
Hayashi, T.、Maeda, K.、Hasekawa, K.、Nakai, S.、Hamachi, T.、Iwta, H.:“表达干扰素 r 的质粒 DNA 可减少哮喘小鼠模型中的晚期过敏性支气管炎”Int
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hayashi T. et al.: "Systemic administration of histamine reduces reovirus type-2-induced insulitis in suckling DBA/1 mice"J. Comp. Path.. 126. 153-160 (2002)
Hayashi T. 等人:“全身施用组胺可减少乳汁 DBA/1 小鼠中 2 型呼肠孤病毒诱导的胰岛炎”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hayashi T., Hasegawa K., et al.: "Reduction of serum IFN-r concentration and lupus development in NZBxNZWF1 mice by LDV infection"J. Comp. Path.. 125. 285-291 (2001)
Hayashi T.、Hasekawa K. 等人:“LDV 感染降低 NZBxNZWF1 小鼠血清 IFN-r 浓度和狼疮发展”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 28 条
    Destruction of niche and target-cells in autoimmune diseases by effector cells and molecules
    • 批准号:
      21580362
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      HAYASHI Toshiharu
    • 依托单位:
    Mechanisms and treatments of autoimmune diseases by Th1/Th2 unbalance
    • 批准号:
      15380210
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.32万
    • 财政年份:
      2003
    • 负责人:
      HAYASHI Toshiharu
    • 依托单位:
    Studies on pathogenesis, prevention and treatment of serious diseases.
    • 批准号:
      10660302
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1998
    • 负责人:
      HAYASHI Toshiharu
    • 依托单位:
    Relations between development of insulitis and expression of adhesion molecules in multiple low-dose streptozotocin-treated mice.
    • 批准号:
      06660381
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1994
    • 负责人:
      HAYASHI Toshiharu
    • 依托单位:
    国内基金
    海外基金
    肠道菌群代谢产物SCFA调控Th1/Th2失衡在儿童过敏性鼻炎中的作用及益生菌靶向干预研究
    • 批准号:
      2026JJ82542
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢骏
    • 依托单位:
    肺滤泡成熟B细胞在哮喘Th2反应中的作用及机制探讨
    • 批准号:
      JCZRLH202600711
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于TSLP-OX40L/Th2通路探讨吸入性过敏原组分在儿童过敏性鼻炎中的致敏机制与临床应用
    • 批准号:
      2026JJ82154
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      罗伶俐
    • 依托单位:
    基于“金虚宜敛”理论探讨过敏煎经“共生菌-肠肺轴-Th1/Th2免疫失衡”途径防治哮喘的药效机制
    • 批准号:
      JCZRLH202600644
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: